Europe Anthrax Treatment Market Size & Outlook, 2025-2033


Europe Anthrax Treatment Market Insights

  • As highlighted in Reed Intelligence analysis, the Europe Anthrax Treatment Market, valued at USD 96.57 Million in 2024, is estimated to achieve USD 160.58 Million by 2033.
  • The market is estimated to grow at a CAGR of 5.82% spanning 2026 to 2033.
  • By market size, Cutaneous Anthrax led the By Disease Type category in 2024.
  • The By Disease Type segment led by Inhalation Anthrax is estimated to post the fastest growth, sustaining its position as the most lucrative during the forecast timeframe.

Other Key Findings


  • The global Anthrax Treatment Market size saw Europe holding a share of 22.85% in 2024.
  • United States is forecasted to account for the leading share of the global market by 2033.
  • In Europe, Nordic is forecasted to be the fastest-expanding market, projected to reach USD 8.43 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 96.57 Million
Market Size In 2033 USD 160.58 Million
Largest segment Cutaneous Anthrax
Units Revenue in USD Million
CAGR 5.82% (2025-2033)
Segmnetation Covered
Europe
  1. Germany
  2. United Kingdom
  3. France
  4. Italy
  5. Spain
  6. Russia
  7. Nordic
  8. Benelux
By Disease Type
  1. Cutaneous Anthrax
  2. Inhalation Anthrax
  3. Gastrointestinal Anthrax
  4. Injection Anthrax
By Treatment Type
  1. Antibiotics
  2. Immunoglobulins
  3. Others
By Route of Administration
  1. Parenteral
  2. Oral
By End-User
  1. Hospitals
  2. Clinics
  3. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports